Search - tctmd.com

Displaying 81 - 100 of 111

Sort: Relevancy | Date

Presentation TVT 2019

AS With… Severe LVOT Calcium

Presenter: * Unassigned0

June 13, 2019

News Conference News EuroPCR 2019

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

Michael O'Riordan

May 23, 2019

News Industry News

Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis

May 07, 2019

News Daily News

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Michael O'Riordan

March 13, 2019

News Conference News CRT 2019

BASILICA Leaflet Laceration Before TAVR Helps Prevent Coronary Obstruction

Yael L. Maxwell

March 04, 2019

News Daily News

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

Yael L. Maxwell

March 01, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2018

Caitlin E. Cox

January 01, 2019

News Features

Top News in Clinical Cardiology: 2018

Yael L. Maxwell

December 28, 2018

Presentation TCT 2018

#3 Calcium, Calcium and more CalciumSevere AS with Heavily Calcified Annulus/LVOT - Case Presentation

Presenter: Tamim Nazif

September 22, 2018

News Industry News

Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

July 24, 2018

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Caitlin E. Cox

May 23, 2018

Podcast TCTMD Talking Points

MITRAL: 30-Day Outcomes of Transcatheter MV Replacement in Severe MV Disease Secondary to Mitral Annular Calcification or Failed Annuloplasty Rings

May 16, 2018

News Conference News CRT 2018

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Shelley Wood

March 05, 2018

News Conference News PCR London Valves 2017

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

Shelley Wood

September 27, 2017

News Daily News

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Leah Lawrence

August 10, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2017

Shelley Wood

July 31, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

News Conference News EuroPCR 2017

More Early Stroke With SAVR Than TAVR in SURTAVI

Shelley Wood

May 18, 2017

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

News Daily News

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

L.A. McKeown

April 12, 2017

Advertisement

AS With… Severe LVOT Calcium

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

BASILICA Leaflet Laceration Before TAVR Helps Prevent Coronary Obstruction

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

TCTMD’s Top 10 Most Popular Stories for December 2018

Top News in Clinical Cardiology: 2018

#3 Calcium, Calcium and more CalciumSevere AS with Heavily Calcified Annulus/LVOT - Case Presentation

Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

MITRAL: 30-Day Outcomes of Transcatheter MV Replacement in Severe MV Disease Secondary to Mitral Annular Calcification or Failed Annuloplasty Rings

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

TCTMD’s Top 10 Most Popular Stories for July 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

More Early Stroke With SAVR Than TAVR in SURTAVI

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content